Oxidative response and membrane modification of diabetic platelets challenged with PAF

Prostaglandins and Other Lipid Mediators

Volumn 62, Issue 4, 2000, Pages 351-366

  Tiano, L ^a   Kantar, A ^a   Falcioni, G ^a   Littarru, G P ^b   Cherubini, V ^b   Fiorini, R ^b  

^a UNIVERSITY OF CAMERINO   (Italy)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGEN PEROXIDE; THROMBOCYTE ACTIVATING FACTOR;

ADOLESCENT; ADULT; ANISOTROPY; ARTICLE; CELL MEMBRANE FLUIDITY; CHEMOLUMINESCENCE; CHILD; CLINICAL ARTICLE; DIABETES MELLITUS; FEMALE; FLUORESCENCE SPECTROSCOPY; HUMAN; HUMAN CELL; MALE; MEMBRANE STRUCTURE; OXIDATIVE STRESS; THROMBOCYTE; THROMBOCYTE MEMBRANE;

ACRIDINES; ADOLESCENT; BLOOD PLATELETS; CELL MEMBRANE; CHEMILUMINESCENCE; CHILD; DIPHENYLHEXATRIENE; FEMALE; FLUORESCENCE POLARIZATION; HUMAN; HYDROGEN PEROXIDE; KINETICS; LUMINOL; MALE; MEMBRANE FLUIDITY; PLATELET ACTIVATING FACTOR; REACTIVE OXYGEN SPECIES; SPECTROMETRY, FLUORESCENCE; SUPEROXIDE DISMUTASE; SUPEROXIDES;

EID: 0033791611     PISSN: 00906980     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-6980(00)00082-4     Document Type: Article

References (43)

1. Platelet activating factor (PAF): A review of its effects, antagonists, and possible future clinical implications (Part I)
2. PAF: A review of its effects, antagonists, and possible future applications (Part II)
3. Platelet-activating factor and related ether lipid mediators. Biological activities, metabolism and regulation
4. Specific receptors of platelet-activating factor, receptor heterogeneity, and signal transduction mechanisms
5. Oxygen free radicals and platelet activation
6. Arterial thrombosis and atherosclerosis in diabetes
7. Diabetes-induced alterations in platelet metabolism
8. Nonenzymatic glycation of platelet proteins in diabetic patients
9. Elevated levels of PAF-acether in blood of patients with type 1 diabetes mellitus
10. Parallel investigation of exocytosis kinetics and membrane fluidity changes in human platelets with the fluorescent probe, trimethylammonio-diphenyl hexatriene
11. Interaction between PAF and human platelet membranes: A fluorescence study
12. Protein measurement with the folin phenol reagent
13. Changes of fluorescence anisotropy in plasma membrane of human polymorphonuclear leukocytes during the respiratory burst phenomenon
14. Platelet plasma membrane in subjects with primary nocturnal enuresis: Effects of desmopressin
15. Probing the interaction of PAF with human platelet membrane using the fluorescent probe laurdan
16. Hydrogen peroxide release from human blood platelets
17. Diphenylene iodonium, an inhibitor of free radical formation, inhibits platelet aggregation
18. Generation of superoxide by purified brain nitric oxide synthase
19. Oxidation reactions by prostaglandin cycloxygenase hydroperoxidase
20. Heme spin states and peroxide-induced radical species prostaglandin H synthase
21. Lucigenin chemiluminescence in the assessment of neutrophil superoxide production
22. Phagocytic leucocyte oxygenation activities and chemiluminescence: A kinetic approach to analysis
23. (±)-Trans-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4, 5-trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel potent, PAF receptor antagonist
24. Effects of anti-oxidant treatment on sciatic nerve dysfunction in streptozotocin-diabetic rats comparison withessential fatty acids
25. Altered platelet membrane dynamic properties in type 1 diabetes
26. Decreased platelet phosphoinositide turnover and enhanced platelet activation in IDDM
27. Increased intracellular calcium and altered phorbol dibutyrate binding to intact platelets in young subjects with insulin-dependent and non-insulin-dependent diabetes mellitus
28. Insulin increases guanosine-3',5'-cyclic monophosphate in human platelets: A mechanism involved in the insulinanti-aggregating effect
29. Insulin stimulate nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3'-5'-cyclic monophosphate andadenosine-3'-5'-cyclic monophosphate
30. On the principles of functional ordering in biological membranes
31. Membrane structure and dynamics
32. Lipid dynamics and peripheral interactions of proteins with membrane surface
33. Lipid domains in model and biological membranes
34. Membrane 'fluidity' as detected by diphenylhexatriene probes
35. TMA-DPH: A suitable fluorescence polarization probe for specific plasma membrane fluidity studies in intact cells
36. Lipid structural order parameters (reciprocal of fluidity) in biomembranes derived from steady-state fluorescence polarization measurements
37. Correlation between the order parameters and the steady state fluorescence anisotropy of 1,6-diphenyl-1,3,5-hexatriene and an evaluation of membrane fluidity
38. Membrane lipid domains and dynamics as detected by laurdan fluorescence
39. Quantitation of lipid phases in phospholipid vesicles by the generalized polarization of laurdan fluorescence
40. Diabetes mellitus alters the effect of peptide and protein ligands on membrane fluidity of blood platelets
41. Changes in phospholipid composition of blood cell membranes (erythrocyte, platelet, and polymorphonuclear) in different types of diabetes: Clinical and biological correlations
42. Exposure of adhesion molecules on activated platelets inpatients with newly diagnosed IDDM is not normalized by near-normoglycemia